
The AptarGroup business segment dedicated to the evolving drug delivery needs of biotechnology, healthcare and pharmaceutical companies, allocating 5% of annual revenue to R&D in pursuit of patient-focused innovation. With manufacturing sites in Argentina, China, France, Germany, India, Switzerland and the US serving the global pharmaceutical market, the company operates through three divisions: Consumer Health Care, Prescription and Injectable.

No hay comentarios disponibles.
Deja tu valoración & comentario